Weaning Methods From Mechanical Ventilation in Adult Patients

In general consideration, our study provided evidence that weaning with proportional assist ventilation has a high probability of being the most effective ventilation mode for patients with mechanical ventilation regarding... read more

Weaning Methods From Mechanical Ventilation in Adult Patients

Optimizing Critical Illness Recovery: Perspectives and Solutions From the Caregivers of ICU Survivors

This qualitative, multicenter, international study of caregivers of critical illness survivors identified consistently unmet needs, means by which caregivers accessed support post ICU, and several care mechanisms identified... read more

Optimizing Critical Illness Recovery: Perspectives and Solutions From the Caregivers of ICU Survivors

Ivermectin Not the Crisis It’s Claimed to Be

I can't remember any time when the U.S. Food and Drug Administration had to resort to the faux-folksy mode of expression to try to get its point across. We live in strange times. The FDA was responding, of course, to the... read more

Ivermectin Not the Crisis It’s Claimed to Be

SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro

Severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) has led to the coronavirus disease 2019 (COVID–19) pandemic, severely affecting public health and the global economy. Adaptive immunity plays a crucial role... read more

SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro

Critical Illness in Patients with Hematologic Malignancy

Critical illness in patients with a newly diagnosed hematologic malignancy is frequent, occurring early after diagnosis. Certain baseline characteristics can help identify those patients at the highest risk. A total of... read more

Critical Illness in Patients with Hematologic Malignancy

EDS: Early or Late in the Diagnostic Process?

Electronic differential diagnostic support (EDS) increased the number of diagnostic hypotheses and the likelihood of the correct diagnosis appearing in the differential, and these effects persisted irrespective of whether... read more

EDS: Early or Late in the Diagnostic Process?

Mechanically Ventilated COVID-19 Patients: Long-term Survival Study

The long-term survival of mechanically ventilated patients with severe COVID-19 reaches more than 50% and may help to provide individualized risk stratification and potential treatments. 868 patients were included (median... read more

Mechanically Ventilated COVID-19 Patients: Long-term Survival Study

Hospitals With and Without Neurosurgery: Evaluating TBI Patients Outcomes

In our study, centralization of TBI patients significantly impacted short- and long-term outcomes. For TBI patients admitted to no-NSH centers, our results suggest that the least critically ill can effectively be managed... read more

Hospitals With and Without Neurosurgery: Evaluating TBI Patients Outcomes

Effect of Statins on Cognitive Outcome After TBI

Traumatic brain injury (TBI), also known as the "Silent Epidemic," is a growing devastating global health problem estimated to affect millions of individuals yearly worldwide with little public recognition, leading to many... read more

Effect of Statins on Cognitive Outcome After TBI

Can Early Cytokine Profile Discriminate Between GPB and GNB?

Sepsis is a principal cause of death in critical care units worldwide and consumes considerable healthcare resources. The aim of our study was to determine whether the early cytokine profile can discriminate between Gram-positive... read more

Can Early Cytokine Profile Discriminate Between GPB and GNB?

Difference in Sepsis Patients Outcomes Between First and Second-Hit Infections

Our study identifies a fundamental difference in patient outcomes between first-hit and second-hit bacterial infections, which may be due to genetic, microbiological, immunological, and environmental factors. This finding... read more

Difference in Sepsis Patients Outcomes Between First and Second-Hit Infections

HIV and COVID-19 Increased Risk of Severe Outcomes

People living with HIV with detectable HIV viraemia, chronic comorbidities, and some subpopulations could be at increased risk of severe outcomes from COVID-19. These groups should be prioritised in clinical management and... read more

HIV and COVID-19 Increased Risk of Severe Outcomes

Impact of Tight Glucose Control on Circulating 3-hydroxybutyrate in Critically Ill Patients

Tight versus liberal glucose control in the context of early parenteral nutrition did not affect 3-hydroxybutyrate concentrations in critically ill patients. Hence, the protective effects of tight glucose control in this... read more

Impact of Tight Glucose Control on Circulating 3-hydroxybutyrate in Critically Ill Patients

Multicomponent Sepsis Transition Effect and Recovery Program After Sepsis

In a multisite randomized clinical trial of patients hospitalized with sepsis, patients provided with a 30-day program using a nurse navigator to provide best practices for postsepsis care experienced a lower proportion of... read more

Multicomponent Sepsis Transition Effect and Recovery Program After Sepsis

Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Among high-risk patients with mild-to-moderate COVID-19, sotrovimab reduced the risk of disease progression. No safety signals were identified. The results of this interim analysis of COMET-ICE indicate that sotrovimab... read more

Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Differential Dynamics of Peripheral Immune Responses to Acute COVID-19 Infection in Older Adults

In this study, peripheral blood mononuclear cells from young and old patients with COVID-19 were examined phenotypically, transcriptionally and functionally to reveal age-, time- and severity-specific adaptations. Gene... read more

Differential Dynamics of Peripheral Immune Responses to Acute COVID-19 Infection in Older Adults

Risk of Death in Hospitalised COVID‐19 Patients Is Not Reduced by Azithromycin Treatment

The effect of antibiotics with potential antiviral and anti‐inflammatory properties are being investigated in clinical trials as treatment for COVID‐19. We are certain that risk of death in hospitalised COVID‐19... read more

Risk of Death in Hospitalised COVID‐19 Patients Is Not Reduced by Azithromycin Treatment

ABCDEF Bundle Implementation for ICU Patients During the COVID-19

Regardless of COVID-19 infection status, implementation rates for the ABCDEF bundle, for each element individually and an ICU diary were extremely low for patients without and with COVID-19 infections during the pandemic.... read more

ABCDEF Bundle Implementation for ICU Patients During the COVID-19